CD BioGlyco is committed to technological innovation and research and development, keeping a real-time eye on glycol nanohydrogel developments and providing our clients with continuous technical support and innovative power. To this end, we launch a glycol nanohydrogel development service and provide cutting-edge solutions.
Get a Quote Now- Home
- Platforms
- GlycoNano™ Platform
- Glycol Nanohydrogel Development
Glycol Nanohydrogel Development Service
Overview of Glycol Nanohydrogel Development Service
The unique properties and nanoscale size of glycol nanohydrogel enable it to be taken up by cells through endocytosis and then release its contents into the cytoplasm through different stimuli. As a result, glycol nanohydrogel offers additional advantages over conventional nanocarriers, such as good targeting, superior encapsulation efficiency, enhanced permeability, and lower cytotoxicity. CD BioGlyco provides a one-stop glycol nanohydrogel development service, including design, preparation, formulation optimization, characterization, preclinical studies, and application evaluation. Our proprietary glycol nanohydrogel synthesis technology ensures high encapsulation rates and uniform particle size distributions and provides extensive support for advancing their applications.
Fig.1 Sources and advantages of nanohydrogels. (Quazi & Park, 2022)
High-quality Development Service: The Cornerstone of Glycol Nanohydrogel Research
Based on the advanced GlycoNano™ Platform and the ability to precisely control uniform particle size, we offer integrated development services and prepare glycol nanohydrogel with high encapsulation efficiency. Regardless of the type of customized glycol nanohydrogel you need, we offer a specific solution for your specific research needs and ensure high precision and quality every step of the way.
Our Techniques for Glycol Nanohydrogel Development
Adjusting the proportions of various components, synthesis temperature, time, etc., has an impact on the properties, structure, and functionalization of glycol nanohydrogel. Based on our extensive practical experience, we select appropriate methods to customize glycol nanohydrogel formulations that precisely deliver the active substance to suit the specific drug, application, and delivery method.
- Precipitation Polymerization-based Glycol Nanohydrogel Development Service
- Inverse Emulsion Polymerization-based Glycol Nanohydrogel Development Service
- Microtemplate-assisted Polymerization-based Glycol Nanohydrogel Development Service
- Precipitation/Crosslinking-based Glycol Nanohydrogel Development Service
- Emulsion/Crosslinking-based Glycol Nanohydrogel Development Service
- Self-assembly/Crosslinking-based Glycol Nanohydrogel Development Service
- Microtemplating/Crosslinking-based Glycol Nanohydrogel Development Service
Glycol Nanohydrogel Development

We select suitable polymeric materials based on the target application and develop various glycol nanohydrogels using various polymers. Commonly used polymers include natural polymers such as chitosan, and gelatin, and synthetic polymers such as polylactic acid (PLA). These compounds functionalize and tailor the hydrogel surface to enhance its interaction with the biological environment or attach specific ligands for targeting purposes. In this process, we consider biocompatibility, hydrogel size, and detailed applications and synthesize glycol nanohydrogel using various methods such as precipitation polymerization, and inverse emulsion polymerization.
Natural polymers come from a wide variety of sources and offer various advantages. Glycol nanohydrogel engineered from natural sources has attracted a lot of attention due to its wide range of applications in agriculture, tissue engineering, cancer therapy, and drug delivery. Isolated polymers of natural origin such as gelatin, chondroitin, alginate, branched chain starch, etc., are known as natural polymers. We use several different strategies to develop glycol nanohydrogel based on various natural polymers, including the following:
- Carbohydrate-based Nanohydrogel Production Service
- Glycosaminoglycan-based Nanohydrogel Production Service
- Polypeptide/Glycoprotein-based Nanohydrogel Production Service
Synthetic polymers are a class of polymers that includes materials consisting of long molecular chains connected by organic linkages. They have a controlled structure, desired mechanical properties, and tunable biodegradability, and are used to prepare glycol nanohydrogel by cross-linking, etc. Commonly used synthetic polymers include PLA, polyvinyl alcohol (PVA), polylactic-co-glycolic acid (PLGA), poly(l-lactic acid) (PLLA), and polydioxanone (PDO), and are suitable for applications such as biomedical applications. Based on our extensive experience in glycol nanohydrogel development, we offer the following glycol nanohydrogel manufacturing services:
- PLA-based Glycol Nanohydrogel Production Service
- PVA-based Glycol Nanohydrogel Production Service
- Polylactic-co-glycolic acid (PLGA)-based Glycol Nanohydrogel Production Service
- Poly (l-lactic Acid) (PLLA)-based Glycol Nanohydrogel Production Service
- Polydioxanone (PDO)-based Glycol Nanohydrogel Production Service
Glycol Nanohydrogel Characterization

The size and distribution of glycol nanohydrogel will affect its embedding characteristics, stability, release behavior, pharmacokinetics, and other properties. We characterize the Physicochemical Properties and Interactions of glycol nanohydrogel to ensure that its structure and properties are as expected. These are typically characterized by dynamic light scattering (DLS), atomic force microscopy (AFM), transmission electron microscopy (TEM), and others.
- Size and morphology: Techniques such as DLS, scanning electron microscopy (SEM), and TEM are used to analyze the size and structure of the particles.
- Mechanical properties: Rheological and compression tests are performed to ensure that glycol nanohydrogel has the correct mechanical properties.
- Swelling and degradation: We evaluate the swelling and degradation rates of glycol nanohydrogel under physiological conditions to predict in vivo behavior.
- Interaction analysis: We analyze the binding affinity of glycol nanohydrogel and its interaction with lipids, proteins, carbohydrates, nucleic acids, etc., in combination with analytical techniques such as DLS.
Preclinical Studies of Glycol Nanohydrogel

We conduct detailed in vitro and in vivo studies using abundant In Vivo and In Vitro Models to analyze the properties, biodistribution, and efficacy of glycol nanohydrogel, such as biocompatibility, cytotoxicity, drug release kinetics, and safety. Depending on the specific application and desired properties of glycol nanohydrogel, the methods and considerations required for the assay vary widely. Preclinical study protocols for different glycol nanohydrogel are customized to meet the specific needs of the intended use.
- Encapsulation rate and loading
The loading and loading rate of glycol nanohydrogel encapsulated actives are examined and further analyzed for their effect on the stability of the actives.
- Stability analysis
Due to long-term storage, the conformation of glycol nanohydrogel may change, resulting in delivery efficiency. It is necessary to determine the Physical, Chemical, and Storage Stability of glycol nanohydrogel. We simulate various environments and determine the stability of glycol nanohydrogel under different conditions.
Cytotoxicity, Uptake and Trafficking, and Immune Responses to glycol nanohydrogel are evaluated by assaying cell proliferation, apoptosis, activity, and cytokines using various cellular and animal models.
The assessment of the pharmacodynamics of glycol nanohydrogel included a Dose-Response Study, Mechanism of Action Study, Tumor Xenograft Study, and Wound Healing Study.
We study the Absorption, Biodistribution, Metabolism, and Excretion of glycol nanohydrogel through in vivo and in vitro experiments, and calculate the half-life of glycol nanohydrogel.
- Safety Pharmacology evaluation
We evaluate the safety pharmacology of glycol nanohydrogel to ensure that it is suitable for specific applications such as drug delivery and skin repair.
- Application analysis
We conduct detailed tests on the release efficiency and encapsulation efficiency of glycol nanohydrogel and evaluate their potential applications in pharmaceuticals, cosmetics, and agriculture.
Advantages of Our Glycol Nanohydrogel Development
- Targeted drug delivery: The glycol nanohydrogel is used to encapsulate the drug and release it at a specific target point, thus minimizing side effects and increasing efficacy.
- Biocompatibility: The glycol nanohydrogel is made from natural polymers and synthetic polymers, which are biocompatible materials, making it suitable for use in various biomedical and cosmetic applications and reducing the risk of rejection or adverse immune reactions.
- Controlled release: The glycol nanohydrogel allows controlled release of various actives and sustained release for a desired period.
- Responsive behavior: The glycol nanohydrogel responds to specific stimuli such as pH, temperature, or enzymes, and is well suited for use in smart drug delivery systems and other responsive applications.
- Versatility: Synthesized glycol nanohydrogel has different physicochemical properties depending on the monomer, etc. and is suitable for various applications.
- Good stability: The glycol nanohydrogel has improved stability, essential for maintaining functionality under physiological conditions.
Workflow

Applications
- Glycol nanohydrogel can be used as a drug delivery system and is used to deliver drugs in a controlled manner to improve the effectiveness of treatments for cancer, cardiovascular diseases, etc., and to reduce side effects.
- Glycol nanohydrogel has good applications in tissue engineering as a scaffolding material to support cell growth and proliferation and to promote the development of new tissues.
- Glycol nanohydrogel also has important applications in biosensors, imaging agent delivery, the cosmetic field, and so on.
Advantages
- Our glycol nanohydrogel development team consists of experienced and professional researchers who provide customized glycol nanohydrogel solutions according to client needs and drive innovation in biomedical, cosmetic, and other fields.
- We use advanced nanotechnology, including preparing glycol nanohydrogel, and optimize it to ensure that the solubility, stability, and bioavailability of the encapsulated actives are effectively increased while reducing their side effects and toxicity.
- Our glycol nanohydrogel services ensure superior quality by covering all aspects of characterization and preclinical studies.
Publication Data
Technology: Nanoprecipitation self-assembly
Journal: Nanomaterials
IF: 5.719
Published: 2021
Results: In this study, a new glyconanoparticle was constructed by nanoprecipitation self-assembly, consisting of polystyrene-block-maltoheptaose and polystyrene-block-β-cyclodextrin. The structure, morphology, and size of the glyconanoparticle were characterized by DLS and SEM. The glyconanoparticle may have good applications in biotechnology, cosmetics, and biomedicine through modification. It may also be developed for enzyme biofuel cells, for example, to convert chemical energy into electrical energy.
Fig.2 Complete development process of glyconanoparticles. (Carrière, et al., 2021)
Frequently Asked Questions
- Do you offer analysis and characterization services?
Absolutely. Our comprehensive analytical and characterization capabilities, including particle size analysis, mechanical property studies, interaction analysis, encapsulation efficiency assessment, drug release profile analysis, stability testing, biological characterization, pharmacokinetic studies, pharmacodynamic studies, and safety and pharmacological evaluations, ensure that glycol nanohydrogel delivers superior performance. -
How long does the specific experimental process take?
The overall glycol nanohydrogel development process varies depending on the specific requirements and assay methods. From glycol nanohydrogel design, synthesis, and characterization to preclinical studies, the overall experimental process ranges from a few weeks to a few months.
CD BioGlyco has many years of expertise in the field of glycol nanohydrogel and continues to provide our collaborators with tailored solutions for glycol nanohydrogel development. If you are looking for the right glycol nanohydrogel for your specific project, we are ready to help you. Please feel free to contact us and discuss your project together.
References
- Quazi, M.Z.; Park, N. Nanohydrogels: advanced polymeric nanomaterials in the era of nanotechnology for robust functionalization and cumulative applications. International Journal of Molecular Sciences. 2022, 23(4): 1943.
- Carrière, M.; et al. Functionalizable glyconanoparticles for a versatile redox platform. Nanomaterials. 2021, 11(5): 1162.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





